-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
ADMA BIOLOGICS, INC. quarterly/annual Depreciation, Depletion and Amortization history and change rate from 2013 to Q3 2025.
- ADMA BIOLOGICS, INC. Depreciation, Depletion and Amortization for the quarter ending 30 Sep 2025 was $2M, a 5.26% increase year-over-year.
- ADMA BIOLOGICS, INC. Depreciation, Depletion and Amortization for the twelve months ending 30 Sep 2025 was $7.9M, a 3.95% increase year-over-year.
- ADMA BIOLOGICS, INC. annual Depreciation, Depletion and Amortization for 2024 was $7.7M, a 1.32% increase from 2023.
- ADMA BIOLOGICS, INC. annual Depreciation, Depletion and Amortization for 2023 was $7.6M, a 18.8% increase from 2022.
- ADMA BIOLOGICS, INC. annual Depreciation, Depletion and Amortization for 2022 was $6.4M, a 33.3% increase from 2021.
Depreciation, Depletion and Amortization, Trailing 12 Months (USD)
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Change (%)
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Change (%)